Active substance
Results for the substance simoctocog alfa coagulation factor viii
4 results
About this active substance
Simoctocog alfa is a recombinant form of coagulation factor VIII used for the treatment and prevention of bleeding episodes in patients with hemophilia A. It works by replacing the missing or deficient factor VIII, restoring normal blood clotting.
The medication is administered intravenously, as directed by a doctor, usually during bleeding episodes or prophylactically. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor factor VIII levels.
Patients should be aware of potential side effects, such as injection site reactions, fever, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, fever, and headaches. In rare cases, severe reactions such as anaphylactic reactions or the development of factor VIII inhibitors may occur. Patients should be informed of these risks before administration.
The medication is administered intravenously, as directed by a doctor, usually during bleeding episodes or prophylactically. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor factor VIII levels.
Patients should be aware of potential side effects, such as injection site reactions, fever, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, fever, and headaches. In rare cases, severe reactions such as anaphylactic reactions or the development of factor VIII inhibitors may occur. Patients should be informed of these risks before administration.
-
-
NUWIQ 1000UI powder and solvent for solution for injection OCTAPHARMA ORIGINAL MEDICINE
-
NUWIQ 500UI powder and solvent for solution for injection OCTAPHARMA ORIGINAL MEDICINE
-
NUWIQ 250UI powder and solvent for solution for injection OCTAPHARMA ORIGINAL MEDICINE